GLP-1GIP agonist
GLP-1GIP agonist
€50 Million Boost for GLP-1 Production in France!
BIOT
🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀
Roche’s Breakthrough Obesity Drug: 188 Weight Loss!
BIOT
🔍 Roche's CT-388 shows promising results in treating obesity, with a median weight loss of 18.8 in Phase I trial. 📈💊🩺
